Last Updated on December 22, 2022 by IANS
New Delhi, Dec 22 (IANS) Amid the sudden Covid scare that has erupted across many countries, a WhatsApp message has been making its rounds claiming that the newly discovered XBB subvariant of Omicron is five times more virulent and has a higher mortality rate than the Delta variant.
However, the Union health ministry has rejected the claim and has termed the message fake. “This message circulating in many WhatsApp groups regarding XXB variant of Covid 19 is FAKE and Misleading”, said the health ministry on Thursday.
The viral message claims that “the new variant of the COVID-Omicron XBB coronavirus is different, deadly and not easy to detect correctly. The symptoms of the new virus COVID-Omicron XBB are – there is no cough and there is no fever.”
“COVID-Omicron XBB is 5 times more virulent than the Delta variant and has a higher mortality rate than it,” the viral message claims further.
In view of the recent surge in Covid-19 cases in China and other countries, the Centre has asked states to step up vigil and gear up genome sequencing of positive case samples to track existing and emerging variants.
Union Health Minister Mansukh Mandaviya on Wednesday chaired a high-level meeting to review the Covid-19 situation in India and preparedness of the public health system for surveillance, containment and management of the virus in view of the recent spike in cases in some countries. The meeting was attended by Minister of State Health Dr Bharati Pravin Pawar, Member (Health) NITI Aayog, Dr V.K. Paul and other senior officials.
–IANS
avr/dpb
Disclaimer: Medical Science is an ever evolving field. We strive to keep this page updated. In case you notice any discrepancy in the content, please inform us at [email protected]. You can futher read our Correction Policy here. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website or it's social media channels. Read our Full Disclaimer Here for further information.
